Biogen Pharmachem Fair Value
Biogen Pharmachem (BIOGEN) average fair value is ₹6.74 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹0.37 (+1721.62%), fair value range ₹0.02–₹15.84. See BIOGEN P/B ratio to compare market price against book value per share.
Fair Value Analysis Export
BIOGEN Fair Value vs Current Price — Valuation Summary
BIOGEN average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). Also explore BIOGEN stock price history to track price trends across different timeframes.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
BIOGEN Fair Value Analysis — Data Sources & Coverage
Biogen Pharmachem financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. For live price and a broader fundamental view, visit Biogen Pharmachem share price screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
BIOGEN vs Financial Services Sector Peers — P/E, P/B & Market Cap
Biogen Pharmachem P/E ratio, P/B ratio and market capitalisation vs Financial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Ajcon Global Services | AJCON | - | 1.55 | ₹39 |
| Shri Niwas Leasing and F… | SHRINIWAS | -0.04 | -0.04 | ₹4 |
| Virat Leasing | VLL | -185.36 | 8.28 | ₹135 |
| Trishakti Electronics | TRISHAKT | 34.09 | 5.69 | ₹252 |
| Indo Credit Capital | INDOCRED | 124.78 | 1.41 | ₹8 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.